Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA’s Absence Raises Concerns About International Standards Development
Feb 06 2025
•
By
Elizabeth Orr
US companies could have trouble selling products overseas if standards are not aligned.
(metamorworks/Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from R&D
More from Legislation